FNBT
GEVA

FineMark National Bank & Trust’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

FineMark National Bank & Trust’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11
Closed -$1K – 1508
2015
Q1 		$1K Hold
11
– – ﹤0.01% 1384
2014
Q4 		$1K Buy
+11
New +$868 ﹤0.01% 1396

FineMark National Bank & Trust's GEVA Position: Q2 2015 in Review

FineMark National Bank & Trust sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 11 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $1K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • FineMark National Bank & Trust reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 11 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • FineMark National Bank & Trust's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on FineMark National Bank & Trust's 13F filing for Q2 2015, filed 11 Aug 2015.